Decreasing reticulocyte counts associated with declining post-dose erythropoietin plasma levels in anaemia of prematurity

Biology of the Neonate

Volumn 74, Issue 6, 1998, Pages 409-415

  Meister, Bernhard ^a   Khoss, August ^b   Burda, Gudrun ^b   Bock, Wolfgang ^c   Kolmer, Micha ^d   Lischka, Andreas ^c   Pollak, Arnold ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c Children's Hospital Glanzing   (Austria)

^d Preyer Children's Hospital   (Austria)

Author keywords

Anaemia of prematurity; Erythropoietin plasma levels; Recombinant human erythropoietin

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HEMATOCRIT; HUMAN; MALE; MULTICENTER STUDY; NEWBORN; NEWBORN ANEMIA; PREMATURITY; PRIORITY JOURNAL; RETICULOCYTE COUNT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANEMIA; ERYTHROPOIETIN, RECOMBINANT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; KINETICS; MALE; PROSPECTIVE STUDIES; RETICULOCYTE COUNT;

EID: 0031761154     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014062     Document Type: Article

References (22)

1. Brown MS, Phibbs RH, Garcia JF, Dallmann PR: Postnatal changes in erythropoietin levels in untransfused premature infants. J Pediatr 1983;103:612-617.
2. Rhondeau SM, Christensen RD, Ross MP, Rothastein G, Simmons MA: Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity". J Pediatr 1988;112:935-940.
3. Shannon KM, Naylor GS, Torkildson JC, Clemons GK, Schaffner V, Goldman SL, Lewis K, Bryant P, Phibbs R: Circulating erythroid progenitors in the anemia of prematurity. N Engl J Med 1987;317:728-733.
4. Shannon KM, Keith JF, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA, Gleason CA, Bifano EM, Millard DD, Davis CB, Stevenson DK, Alverson DC, Simmons CF, Brim M, Abels RI, Phibbs RH: Recombinant human erythropoietin stimulates erythropoiesis in very low birth weight preterm infants. Pediatrics 1995;95:1-8.
5. Strauss RG: Editorial; Erythropoietin and neonatal anemia. N Engl J Med 1994;330:1227-1228.
6. Williams JA, Christ WM: Erythropoietin-not yet a standard treatment for anemia of prematurity (editorial). Pediatrics 1995;95:9-10.
7. Bechensteen AG, Hågå P, Halvorsen S, Whitelaw A, Liestøl K, Lindemann R, Grøgaard J, Hellebostad M, Saugstad OD, Grønn M, Daae L, Refsum H, Sundal E: Erythropoietin, protein and iron supplementation and the prevention of anemia of prematurity. Arch Dis Child 1993; 69:19-23
8. Maier RF, Obladen M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, Hallinday HL, Versmold HT, Moriette G, Jorch G, Verellen G, Semmekrot BA, Grauel EL, Holland BM, Wardrop CAJ: The effect of Epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med 1994;330: 1173-1178.
9. Meyer MP, Meyer JH, Path M, Commerford A, Hann FM, Sive AA, Moller G, Jacobs P, Malan AF: Recombinant human erythropoietin in the treatment of anemia of prematurity: Results of a double-blind, placebo-controlled study. Pediatrics 1994;93:918-923.
10. Messer J, Haddad J, Lionel D, Astruc D, Matis J: Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1993;92:519-523.
11. Lim VS, DeGowin RL, Zavala D, Kirchner PT, Abels R, Perry P, Fangman J: Recombinant human erythropoietin treatment in pre-dialysis patients. Ann Intern Med 1989;110:108-114.
12. McMahon FG, Vargas R, Ryan M, Jain AK, Abels RI, Perry B, Smith IL. Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. Blood 1990;76:1718-1722.
13. Besarab A, Flaharty KK, Erslev AJ, McCrea JB, Vlasses PH, Medina F, Caro J, Morris E: Clinical pharmakology and economics of recombinant human erythropoietin in endstage renal disease; the case for subcutaneous administration. J Am Soc Nephrol 1992;2:1405-1416.
14. Ohls RK, Veermann MW, Christensen RD: Pharmacokinetic and effectiveness of recombinant erythropoietin administered to preterm infants by continous infusion in total parenteral nutrition solution. J Pediatr 1996;128:518-523.
15. Meister B, Herold M, Mayr A, Widschwendter M, Maurer H, Heim K, Sperl W: Interleukin-3, interleukin-6, granulocyte-macrophage colony-stimulating factor and erythropoietin cord blood levels of preterm and term neonates. Eur J Pediatr 1993;152:569-573.
16. Ohls RK, Liechty KW, Turner MC, Kimura RE, Christensen RD: Erythroid burst promoting activity in serum of patients with anemia of prematurity. J Pediatr 1990;116: 786-789.
17. Alfrey CP, Rice L, Udden MM, Driscol TB: Neocytolysis: physiological down-regulator of red cell mass. Lancet 1997;349:1389-1390.
18. Pavlovic-Kentera V, Clemons GK, Biljanovic-Paunovic L, Marisavljevic D, Lezaic V, Prokrajac M, Djukanovic L: Serum erythropoietin levels in hemodialysed patients after administration of recombinant human erythropoietin. Biomed Pharmacother 1992;46:37-43.
19. Brockmoller J, Kochling J, Weber W, Looby M, Roots I, Neumayer H: The pharmacokinetics and pharmacodynamics of recombinant human erythropoietin. Br J Clin Pharmacol 1992;34:499-508.
20. Sawyer ST, Krantz SB, Goldwasser E: Binding and receptor-mediated endocytosis of erythropoietin in friend virus-infected erythroid cells. Biol Chem 1987;262:5554-5562.
21. Widness JA, Veng-Pedersen P, Peters CH, Pereira LM, Schmid RL, Lowe LS: Erythropoietin pharmacokinetics in premature infants: Developmental, non-linearity and treatment effects. J Appl Physiol 1996;80:140-148.
22. Caro J, Brown S, Miller O, Murray T, Erslev AJ: Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med 1979;93:449.